Makandjou-Ola Eusebio
About
In The Last Decade
Makandjou-Ola Eusebio
20 papers receiving 251 citations
Peers
Comparison fields: 5 of 61
- Physiology 105
- Immunology 69
- Pulmonary and Respiratory Medicine 49
- Molecular Biology 45
- Pathology and Forensic Medicine 45
Countries citing papers authored by Makandjou-Ola Eusebio
This map shows the geographic impact of Makandjou-Ola Eusebio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Makandjou-Ola Eusebio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Makandjou-Ola Eusebio more than expected).
Fields of papers citing papers by Makandjou-Ola Eusebio
This network shows the impact of papers produced by Makandjou-Ola Eusebio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Makandjou-Ola Eusebio. The network helps show where Makandjou-Ola Eusebio may publish in the future.
Co-authorship network of co-authors of Makandjou-Ola Eusebio
This figure shows the co-authorship network connecting the top 25 collaborators of Makandjou-Ola Eusebio. A scholar is included among the top collaborators of Makandjou-Ola Eusebio based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Makandjou-Ola Eusebio. Makandjou-Ola Eusebio is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 2 | |
| 5 | 5 | |
| 6 | 24 | |
| 7 | 5 | |
| 8 | 1 | |
| 9 | Comparison of changes in the percentages of CD8+CD28-TCRalpha beta+ T cell subpopulations in allergic asthma subjects vs controls before and after anti-CD3/anti-CD28/IL-2 stimulation in vitro. | 1 |
| 10 | Allergy-related changes in levels of CD8+CD25+FoxP3(bright) Treg cells and FoxP3 mRNA expression in peripheral blood: the role of IL-10 or TGF-beta. | 15 |
| 11 | 3 | |
| 12 | 29 | |
| 13 | Phenotypic characterization of ex vivo CD4+CD25highCD127low immune regulatory T cells in allergic asthma: pathogenesis relevance of their FoxP3, GITR, CTLA-4 and FAS expressions. | 13 |
| 14 | Low frequency of CD8+CD25+FOXP3(BRIGHT) T cells and FOXP3 mRNA expression in the peripheral blood of allergic asthma patients. | 11 |
| 15 | 70 | |
| 16 | 1 | |
| 17 | 4 | |
| 18 | Manganese superoxide dismutase (MnSOD) gene (Ala-9Val, Ile58Thr) polymorphism in patients with age-related macular degeneration (AMD). | 22 |
| 19 | Naturalne regulatorowe limfocyty T u chorych na astmę oskrzelową | 1 |
| 20 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.